Evidence map›Paper›PMID 42399519›Full record

ArticleThe EMBO journal2026

Scalable phosphotyrosine enrichment with SH2 superbinder enables deep profiling of EGF responses.

Alexis T Chang, Ricard A Rodriguez-Mias, Matthew D Berg, Sophie Moggridge, Judit Villén

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexis T ChangDepartment of Genome Sciences, University of Washington, Seattle, 98195, USA.ORCID http://orcid.org/0000-0002-0822-8136
Ricard A Rodriguez-MiasDepartment of Genome Sciences, University of Washington, Seattle, 98195, USA.ORCID http://orcid.org/0000-0001-7960-6387
Matthew D BergDepartment of Genome Sciences, University of Washington, Seattle, 98195, USA.ORCID http://orcid.org/0000-0002-7924-9241
Sophie MoggridgeDepartment of Genome Sciences, University of Washington, Seattle, 98195, USA.
Judit VillénDepartment of Genome Sciences, University of Washington, Seattle, 98195, USA. jvillen@uw.edu.ORCID http://orcid.org/0000-0002-1005-1739

Funding

INTERDISCIPLINARY TRAINING IN GENOMIC SCIENCEST32HG000035 · NHGRI · UNIVERSITY OF WASHINGTON · PI Bruce Colston Trapnell · 1995 to 2026
$24.2M
Emergent properties of signaling network degradation that mediate homeostatic failure during agingR01AG056359 · NIA · UNIVERSITY OF WASHINGTON · PI KAEBERLEIN, MATT, VILLEN, JUDIT · 2017 to 2021
$2.9M
Towards a comprehensive roadmap of cellular signaling.R35GM119536 · NIGMS · UNIVERSITY OF WASHINGTON · PI VILLEN, JUDIT · 2016 to 2020
$2.2M
The role of phosphorylation in the cellular organization of the proteomeR35GM152061 · NIGMS · UNIVERSITY OF WASHINGTON · PI Judit Villen · 2024 to 2026
$1.3M
Canadian Institutes of Health Research (CIHR) MFE-193932HHS | NIH | National Human Genome Research Institute (NHGRI) T32HG000035HHS | NIH | National Institute of General Medical Sciences (NIGMS) R35GM119536HHS | NIH | National Institute of General Medical Sciences (NIGMS) R35GM152061HHS | NIH | National Institute on Aging (NIA) R01AG056359Human Frontier Science Program (HFSP) RGP0034/2018NHGRI NIH HHS T32 HG000035NIA NIH HHS R01 AG056359NIGMS NIH HHS R35 GM119536NIGMS NIH HHS R35 GM152061
6 · The paper itself

Abstract

Phosphotyrosine signaling plays a critical role in many biological processes, from cell proliferation to immune response. Despite its importance, proteomic studies of tyrosine phosphorylation have been limited in scale and throughput due to the need for specialized enrichment with costly reagents and labor-intensive protocols. To address these challenges, we developed R2HaPpY, a phosphotyrosine enrichment method that combines highly simplified phosphotyrosine superbinder reagent preparation and automated high-throughput enrichment. Our new reagent binds phosphotyrosine peptides at higher efficiency than other enrichment reagents and reduces both cost and preparation time by 20-fold. We generalized the R2HaPpY method to samples of low and high levels of phosphotyrosine. We benchmarked biological application to study EGF signaling dynamics in HeLa cells. Using only ~1 mg of input peptides, we detect and quantify 1651 unique phosphotyrosine sites. These include 878 regulated pY sites, many of which are novel or not previously annotated as EGF-responsive. Our results reveal differential temporal regulation and represent the largest phosphotyrosine dataset of cellular response to EGF stimulation to date. This streamlined, cost-effective, and sensitive method enables quantitative mapping of tyrosine phosphorylation dynamics at a scale of hundreds of samples, facilitating integration of phosphotyrosine signaling into multiomic studies across diverse biological systems and disease states.

Indexed as

Epidermal Growth FactorPhosphotyrosineProteomicssrc Homology DomainsHeLa CellsHumansPhosphorylationSignal TransductionEpidermal Growth FactorPhosphotyrosine

Identifiers

PMID42399519
PMCPMC13434655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.